Entera Bio Ltd. — Director's Dealing 2022

Jan 14, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: Santora Arthur C II (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.97	2029-01-17	Ordinary Shares, par value NIS 0.0000769 per share (25000)		Direct
Stock Option (right to buy)	$2.14	2030-03-16	Ordinary Shares, par value NIS 0.0000769 per share (40000)		Direct

Footnotes

F1: The options vest over a four-year period that commenced on January 17, 2019, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.

F2: The options vest over a four-year period that commenced on March 16, 2020, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.